Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
January 21, 2021
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors
Neil T Conlon, Jeffrey J Kooijman, Suzanne J C van Gerwen, et al.
BMC Nephrology
|
June 27, 2019
Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis
G Gorham, K Howard, Y Zhao, et al.
Translational Oncology
|
August 27, 2024
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
Neil T Conlon, Sandra Roche, Amira F Mahdi, et al.
Plos One
|
March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
Sandra Roche, Patricia Gaule, Deirdre Winrow, et al.
International Journal of Molecular Sciences
|
February 7, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
Sandra Roche, Fiona O'Neill, Jean Murphy, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
Riccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.
Proteomes
|
November 9, 2018
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
Orla Coleman, Michael Henry, Fiona O'Neill, et al.
Life (Basel, Switzerland)
|
March 29, 2023
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors
Fiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, et al.
Renal Failure
|
September 12, 2019
Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland
S Cormican, D M Connaughton, C Kennedy, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
January 21, 2021
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors
Neil T Conlon, Jeffrey J Kooijman, Suzanne J C van Gerwen, et al.
BMC Nephrology
|
June 27, 2019
Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis
G Gorham, K Howard, Y Zhao, et al.
Translational Oncology
|
August 27, 2024
Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
Neil T Conlon, Sandra Roche, Amira F Mahdi, et al.
Plos One
|
March 15, 2023
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
Sandra Roche, Patricia Gaule, Deirdre Winrow, et al.
International Journal of Molecular Sciences
|
February 7, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients
Sandra Roche, Fiona O'Neill, Jean Murphy, et al.
Therapeutic Advances in Medical Oncology
|
February 18, 2020
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
Alexandra Canonici, Alacoque L Browne, Mohamed F K Ibrahim, et al.
International Journal of Molecular Sciences
|
April 30, 2021
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
Riccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.
Proteomes
|
November 9, 2018
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
Orla Coleman, Michael Henry, Fiona O'Neill, et al.
Life (Basel, Switzerland)
|
March 29, 2023
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors
Fiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, et al.
Renal Failure
|
September 12, 2019
Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland
S Cormican, D M Connaughton, C Kennedy, et al.
Page
of 5